BridgeMD
New treatment option for Hypertension in Pregnancy
Official title Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
ClinicalTrials.gov ID: NCT06466161
What this study is testing
- What it's testing
- The diagnosis of hypertensive disease during pregnancy is predicated on strict blood pressure thresholds: 140/90 on at least two occasions measured four hours apart for both gestational hypertension and preeclampsia. An improvement in diagnostic accuracy of even 5mm Hg would be significant, as reflected by the US Association for the Advancement of Medical Instrumentation (AAMI), the British Hypertension Society, the European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring, and the International Organization for Standardization (ISO)consensus for validation of non-invasive blood pressure (NIBP) devices during pregnancy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women who are 18 years of age or older with a
- Body mass index (BMI) of 20 kg/m2 or greater
- Present to Labor and Delivery with or without a diagnosis of gestational hypertension, preeclampsia, or chronic hypertension with super-imposed...
You likely can't join if
- Significant peripheral arterial disease resulting in at least a 10 mm Hg blood pressure difference between both arms
- History of repaired or unrepaired congenital heart disease
- History of significant arrythmia
- History of pacemaker or implantable cardioverter defibrillator placement
- History of sickle cell disease
- History of Raynaud's phenomenon on any extremity
See the full eligibility criteria
- Women who are 18 years of age or older with a
- Body mass index (BMI) of 20 kg/m2 or greater
- Present to Labor and Delivery with or without a diagnosis of gestational hypertension, preeclampsia, or chronic hypertension with super-imposed preeclampsia, in spontaneous labor or for induction of labor
- Significant peripheral arterial disease resulting in at least a 10 mm Hg blood pressure difference between both arms
- History of repaired or unrepaired congenital heart disease
- History of significant arrythmia
- History of pacemaker or implantable cardioverter defibrillator placement
- History of sickle cell disease
- History of Raynaud's phenomenon on any extremity
- History of lymph node dissection of either upper extremity
- Patients who are less than 18 years of age
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.